- Home
- About
- 🤖 AskAnzal AI Advisor
- 📅 Book a Call
- Your Account
- My AskAnzal Account
Over 2,000 real rulings — analysed for what they mean to your team. Published every day.
Showing 1914 cases
MIMS print ad implied all Symbicort strengths could be used for MART, despite 400/12 being maintenance-only, and failed to reference where PI…
Anonymous complaint alleged a Guardian-sponsored corporate article was disguised promotion and misleading. PMCPA Panel ruled no breach of Clauses 3.6, 5.1, 6.1,…
GSK’s HCP website described Trelegy Ellipta as “A simple choice. One inhaler, easy to use and quick to teach”. A health professional…
Pfizer UK posted three public tweets linking to a Pulse Today sponsored article. Panel found the article not promotional and no POM…
A Germany-based employee posted “Hope for patients with Lennox-Gastaut Syndrome!” linking to a US press release about Fintepla. A senior UK employee…
AGB’s Adaflex branded webpage (intended for HCPs) became publicly accessible via a Google-indexed direct link, leading to breaches for website access controls…
PMCPA found Novo Nordisk breached Clauses 2, 5.1/9.1 and 28.1 over pharmacy-chain sponsorships that weren’t truly arm’s length, free consumables seen as…
Complaint said a Rinvoq HCP webinar registration page gave dosing but omitted the SmPC grapefruit avoidance warning. Panel found the page wasn’t…
Complaint about a regional e-consent proposal and alleged proactive sharing of preprint data/off-label risk. Panel found the complainant provided limited evidence and…
Anonymous complaint alleged inadequate whistleblowing processes and potential off-label promotion via a Moderna US webcast. Panel found the complainant did not prove…
A Sanofi Global employee’s LinkedIn job update included three product brand names and was liked/commented on by UK staff. Panel found the…
A US-only Apretude in-app advert was briefly visible to UK users after geo-restrictions failed. Panel initially found a Clause 5.1 breach, but…
Third‑party publisher email implied an unbiased ESMO update but linked to a page integrating Novartis Pluvicto promotion. UK HCPs saw EU SmPC/indication,…
Ex-employee alleged excessive alcohol/hospitality and inducement to prescribe at a conference, plus a poorly attended workshop becoming a “pseudo advisory board”. Panel…
Ex-employee complaint about Ontozry meetings. Panel found off-label promotion (incl PEG administration and monotherapy advocacy), references to EMA, and multiple certification/PI/AE statement…
Anzal, our PMCPA rulings expert, has knowledge of over 2,000 published cases — ask about precedents, clauses, and how they apply to your situation.
One real case. One key lesson. Every week — free.